Compare · BIO vs INBS
BIO vs INBS
Side-by-side comparison of Bio-Rad Laboratories Inc. (BIO) and Intelligent Bio Solutions Inc. (INBS): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both companies sit in the Health Care sector. BIO focuses on Biotechnology: Laboratory Analytical Instruments, while INBS focuses on Medical/Dental Instruments.
- BIO is the larger of the two at $9.63B, about 1861.7x INBS ($5.2M).
- INBS has been more active in the news (5 items in the past 4 weeks vs 2 for BIO).
- BIO has more recent analyst coverage (12 ratings vs 0 for INBS).
- Company
- Bio-Rad Laboratories Inc.
- Intelligent Bio Solutions Inc.
- Price
- -
- -
- Market cap
- $9.63B
- $5.2M
- 1M return
- -
- -
- 1Y return
- -
- -
- Industry
- Biotechnology: Laboratory Analytical Instruments
- Medical/Dental Instruments
- Exchange
- NYSE
- NASDAQ
- IPO
- 1980
- 2020
- News (4w)
- 2
- 5
- Recent ratings
- 12
- 0
Bio-Rad Laboratories Inc.
Bio-Rad Laboratories, Inc. develops, manufactures, and markets life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company offers products and systems to separate complex chemical and biological materials, as well as to identify, analyze, and purify components. It operates in two segments, Life Science and Clinical Diagnostics. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, and laboratory instruments that are used in research techniques, biopharmaceutical production processes, and food testing regimes. It focuses on selected segments of the life sciences market in proteomics, genomics, biopharmaceutical production, cell biology, and food safety. This segment serves universities and medical schools, industrial research organizations, government agencies, pharmaceutical manufacturers, biotechnology researchers, food producers, and food testing laboratories. The Clinical Diagnostics segment designs, manufactures, sells, and supports test systems, informatics systems, test kits, and specialized quality controls for clinical laboratories in the diagnostics market. This segment offers reagents, instruments, and software, which address specific niches within the in vitro diagnostics test market. It sells its products to reference laboratories, hospital laboratories, state newborn screening facilities, physicians' office laboratories, transfusion laboratories, and insurance and forensic testing laboratories. The company offers its products through its direct sales force, as well as through distributors, agents, brokers, and resellers. Bio-Rad Laboratories, Inc. was founded in 1952 and is headquartered in Hercules, California.
Latest BIO
- Bio-Rad Reports Third-Quarter 2026 Financial Results
- Bio-Rad to Participate in Fireside Chat During UBS Global Healthcare Conference
- Bio-Rad to Report Third-Quarter 2026 Financial Results on Wednesday, November 4, 2026
- Bio-Rad to Participate in Fireside Chat During Bernstein Insights Healthcare Leaders and Disruptors 3rd Annual Forum
- Bio-Rad to Participate in Fireside Chat During Wells Fargo’s 21st Annual Healthcare Conference
- IMDX Reports Second Quarter 2026 Results and Timely Progress on FDA Review of GraftAssureDx
- Bio-Rad Reports Second-Quarter 2026 Financial Results
- Bio-Rad to Report Second-Quarter 2026 Financial Results on Tuesday, August 4, 2026
- RBC Capital Mkts resumed coverage on Bio-Rad Labs with a new price target
- Bio-Rad to Participate in Upcoming Investor Conferences
Latest INBS
- Intelligent Bio Solutions Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
- SEC Form 10-Q filed by Intelligent Bio Solutions Inc.
- Intelligent Bio Solutions Reports Record Fiscal First Quarter 2027 Revenue of $1.39 Million, Marking Sixth Consecutive Quarter of Year-Over-Year Growth
- Intelligent Bio Solutions to Present at the Webull Biotech Webinar on November 12
- SEC Form DEF 14A filed by Intelligent Bio Solutions Inc.
- SEC Form PRE 14A filed by Intelligent Bio Solutions Inc.
- Amendment: SEC Form 10-K/A filed by Intelligent Bio Solutions Inc.
- SEC Form 8-K filed by Intelligent Bio Solutions Inc.
- SEC Form EFFECT filed by Intelligent Bio Solutions Inc.
- SEC Form 424B3 filed by Intelligent Bio Solutions Inc.